Abstract
The relationship between the use of anti-hypertensive drugs and cancer risk remains controversial.The main objective of this study was to assess the effects of beta-blocker use on cancer risk. Methods:In a cohort of 839 patients with cardiovascular disease, followed up prospectively for a mean of 10years, we compared the risk of cancer in subjects who had and had not received beta-blockers. We estimated therelative risk of cancer associated with beta-blocker use with a Cox model adjusted for sex and age. The use ofbeta-blockers and the duration of exposure to the drug were analyzed as time-dependent variables. We alsocalculated standardized incidence ratios (SIR) from the corresponding age- and sex-adjusted cancer incidencesin the French general population. Results: A total of 326 beta-blocker users and 513 subjects on other treatments were included in the cohort.During the follow-up period, corresponding to 8,466 person-years, 15 incident cancer cases occurred in beta-blocker users and 59 occurred in patients who had never used beta-blockers. The Cox model estimated theoverall relative risk of cancer at 0.51 (95% confidence interval [CI]: 0.29-0.90) in the beta-blocker users,compared with those who had never used beta-blockers (p= 0.02), with a 6% decrease per year of use (95% CI:1%-12%p= 0.03). The corresponding SIR ratio between these two groups was 0.44 (CI: 0.24-0.76) Conclusion: In this cohort, beta-blocker treatments appeared to decrease the risk of cancer significantly.However, this result should be interpreted with caution, as biases inherent in this type of epidemiologicalstudy cannot be totally excluded.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.